ProQR Therapeutics N.V.
PRQR · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 11, 2026 | — | 4.56M | — | -0.14 | — |
| 2026 Q1 | May 12, 2026 | 2.03M | 5.19M | -0.13 | -0.15 | -3.64% |
| 2025 Q4 | March 12, 2026 | 5.54M | 6.63M | -0.09 | -0.08 | +5.81% |
| 2025 Q3 | November 6, 2025 | 3.41M | 6.12M | -0.12 | -0.10 | +0.45% |
| 2025 Q2 | August 7, 2025 | 4.49M | 5.49M | -0.14 | -0.08 | — |
| 2025 Q1 | May 7, 2025 | 4.95M | 4.80M | -0.11 | -0.09 | +3.87% |
| 2024 Q4 | March 13, 2025 | 4.46M | 5.45M | -0.10 | -0.07 | -5.95% |
| 2024 Q3 | November 7, 2024 | 4.21M | 7.00M | -0.11 | -0.12 | -0.50% |
| 2024 Q2 | August 8, 2024 | 6.81M | 12.04M | -0.03 | -0.12 | — |
| 2024 Q1 | May 9, 2024 | 4.81M | 2.82M | -0.10 | -0.12 | — |
| 2023 Q4 | March 13, 2024 | 3.52M | 17.43M | -0.08 | -0.08 | — |
| 2023 Q3 | November 7, 2023 | 1.45M | 12.66M | -0.08 | -0.06 | +2.96% |
| 2023 Q2 | August 3, 2023 | 1.31M | 1.71M | -0.11 | -0.12 | +5.59% |
| 2023 Q1 | May 16, 2023 | 712.12K | 1.42M | -0.12 | -0.12 | +8.05% |
| 2022 Q4 | March 29, 2023 | 885.43K | 1.02M | -0.16 | -0.20 | +7.04% |
| 2022 Q3 | November 9, 2022 | 933.60K | 822.20K | -0.34 | -0.23 | -0.01% |